Prezista

New HIV Study Shows That Large Numbers of Women and People of Color Can Be Successfully Enrolled In U.S. HIV Clinical Studies

...ced women and men receiving the protease inhibitor prezista (600 mg twice daily with 100 mg ritonavir), with a...ences in the efficacy, safety, and tolerability of prezista tablets with 100 mg ritonavir in treatment-experie...copies/mL at week 48. Study participants received prezista (600 mg) boosted with a low dose of ritonavir (100...

PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy

...vailability of a lower-dose (75 mg) formulation of prezista (darunavir) for pediatric patients with HIV. The a...years of age and older, granted December 18, 2008. prezista was developed by Tibotec Pharmaceuticals, Ltd. and...Memorial Hospital in Chicago. "The availability of prezista in a formulation designed especially for children ...

Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results

...se in treatment-experienced adult patients. Outside the United States, the European Commission granted full approval of the Marketing Authorization of prezista in combination with ritonavir and other antiretroviral medicinal products for the treatment of HIV-1 infection, and extended the indication to include...

Prezista in Medical Technology

Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults

...those who have never taken HIV medication before). prezista was developed by Tibotec Pharmaceuticals and is ma...r community long-term efficacy and safety data for prezista in treatment-naive adult patients," said Tony Mill...eatment-experienced adult patients, the dosing for prezista remains 600 mg taken with 100 mg ritonavir twice d...

AHF Criticizes Tibotec Over Steep Price for Newest AIDS Drug, Etravirine

...HIV/AIDS drug at a price well above other drugs in its class -- close to $10,000 per patient per year. According to Tibotec's own website at the time, prezista had been found to be, " ... highly-active in vitro against HIV with Protease Inhibitor resistance mutations...," and was found to be particularly effe...

Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration

...ta from the Phase 2b studies, POWER 1, 2, and 3. prezista received accelerated approval in June 2006 based o...on July 24, 2007. Important Safety Information prezista does not cure HIV infection or AIDS, and does not prevent passing HIV to others. prezista is contraindicated in patients with known hypersen...

New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy

...mation regarding the potential use of a once daily prezista regimen for the treatment of adult patients who ha...tment-naive adult patients or pediatric patients. prezista received accelerated approval in June 2006 based o...he lopinavir/r arm. Important safety information prezista does not cure HIV infection or AIDS, and does not ...

New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV

... information that adds to the body of knowledge on prezista in a much broader group of treatment-experienced p...nt-naive adult patients or pediatric patients. prezista received accelerated approval in June 2006 based o... lopinavir/r arm. Important Safety Information prezista does not cure HIV infection or AIDS, and does not ...

Prezista in Biological Technology

According to AlphaDetail, Inc. Merck and Tibotec Therapeutics Lead Among Infectious Disease Specialists

...s in initiating earlier treatment, the approval of a new dosing regimen for prezista in naive patients, and data about newer HIV treatments showing promise as 1... "There was new data presented on HIV treatment regarding use of either prezista or raltegravir as first-line agents". -...